News | March 11, 2023
Bachem raises $116 million through capital increase
Company will invest in capacity increases, technological capabilities and long-term partnerships with key pharmaceutical and biotech companies
Company will invest in capacity increases, technological capabilities and long-term partnerships with key pharmaceutical and biotech companies
The business serves the healthcare and laboratory sectors on the west coast of the United States.
This new capability represents a significant shift from a microscope-based standard of care to the use of digital whole slide images
Plantasens Pro LM is 100% natural, readily biodegradable, COSMOS and Natrue certified
The Development Center with its state-of-the art laboratories and flexible pilot capacities is set to become Siegfried's global research and development hub for its Drug Products sites, strengthening the global network
Ashland’s pharmaceutical business is well known for acetylenics, cellulosics, and film coatings
Resomer used in commercial 3D-printed implants for both soft and hard tissue applications
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
The new powder flow tester can characterize powder flow properties, offering valuable insight for pharmaceutical processing and formulation
Digital success is contingent on the way a company organizes itself around technology
Subscribe To Our Newsletter & Stay Updated
